Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Topical |
Dose: Topical – Apply sparingly to the affected area Frequency: at night, in the morning and after each evacuation up to a maximum of 4 applications a day Duration: maximum period of one week Note: Use for a maximum period of one week. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Not applicable – No approved dosage Note: No approved pediatric dosage available |
Administration
- Clean affected area thoroughly
- For internal use, use provided nozzle
Side Effect
- Hypersensitivity
- Application site reactions
- Blurred Vision
- Erythema
- Exfoliation
- Irritation
- Pain
- Pruritus
- Rash and Urticaria
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Other corticosteroid preparations (topical or oral)
|
May increase the likelihood of systemic effects
|
|
CYP3A inhibitors, including cobicistat containing products
|
Expected to increase the risk of systemic effects
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Tubercular Lesions
|
Can worsen infection
|
|
Fungal and Viral Lesions
|
Can worsen infections
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Do not store above 30°C & keep in a dry place. Protect from light. Do not freeze Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.